SG
IBB icon

StoneX Group’s iShares Biotechnology ETF IBB Stock Holding History

StoneX Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$553K Buy
3,292
+520
+19% +$88.9K 0.03% 391
2025
Q4 		$469K Buy
2,772
+919
+50% +$149K 0.02% 551
2025
Q3 		$268K Sell
1,853
-276
-13% -$37.7K 0.01% 732
2025
Q2 		$269K Sell
2,129
-15
-0.7% -$1.84K 0.01% 692
2025
Q1 		$274K Buy
2,144
+245
+13% +$33.2K 0.02% 674
2024
Q4 		$251K Sell
1,899
-248
-12% -$34.9K 0.01% 677
2024
Q3 		$313K Buy
2,147
+91
+4% +$13.2K 0.14% 203
2024
Q2 		$282K Sell
2,056
-14
-0.7% -$1.87K 0.13% 222
2024
Q1 		$284K Sell
2,070
-32
-2% -$4.37K 0.15% 198
2023
Q4 		$286K Sell
2,102
-154
-7% -$18.8K 0.15% 193
2023
Q3 		$276K Sell
2,256
-424
-16% -$53.9K 0.15% 200
2023
Q2 		$340K Sell
2,680
-12
-0.4% -$1.56K 0.19% 154
2023
Q1 		$348K Sell
2,692
-134
-5% -$17.5K 0.21% 147
2022
Q4 		$371K Sell
2,826
-110
-4% -$14.2K 0.05% 267
2022
Q3 		$343K Sell
2,936
-1,613
-35% -$200K 0.06% 200
2022
Q2 		$535K Sell
4,549
-1,801
-28% -$214K 0.09% 164
2022
Q1 		$827K Buy
6,350
+3,867
+156% +$504K 0.08% 219
2021
Q4 		$379K Buy
2,483
+248
+11% +$38.4K 0.04% 350
2021
Q3 		$361K Buy
2,235
+444
+25% +$74.7K 0.05% 315
2021
Q2 		$293K Buy
1,791
+463
+35% +$71.3K 0.04% 362
2021
Q1 		$200K Buy
+1,328
New +$211K 0.04% 399
2019
Q2 		– Sell
-1,798
Closed -$201K – 247
2019
Q1 		$201K Buy
+1,798
New +$197K 0.15% 218
2018
Q4 		– Sell
-2,002
Closed -$244K – 219
2018
Q3 		$244K Buy
+2,002
New +$236K 0.18% 196

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

StoneX Group's IBB Position: Q1 2026 in Review

StoneX Group increased its iShares Biotechnology ETF (IBB) stake by 19% in Q1 2026, buying an estimated $88.9K and bringing the position to 3,292 shares worth $553K. The position accounts for 0.03% of the portfolio, ranked #391.

StoneX Group first reported a position in IBB in Q3 2018 and has held it in 23 quarters since. The position peaked at $827K in Q1 2022. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • StoneX Group held 3,292 shares of iShares Biotechnology ETF worth $553K as of Q1 2026.
  • StoneX Group bought 520 iShares Biotechnology ETF shares in Q1 2026, an estimated $88.9K.
  • iShares Biotechnology ETF made up 0.03% of StoneX Group's portfolio in Q1 2026, its #391 holding.
  • StoneX Group first reported a position in iShares Biotechnology ETF in Q3 2018 and has held it in 23 quarters since.
  • StoneX Group's iShares Biotechnology ETF position peaked at $827K in Q1 2022.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.